Sudeep Pharma Limited (NSE: SUDEEPPHRM) stock breaks out with an 8% intraday gain, clearing its 6-month resistance trendline at ₹1141.3.
Aarti Pharmalabs Limited (NSE: AARTIPHARM) stock price gains 9% intraday, breaking out from its 6-month resistance trendline. Current price stands at ₹900.2.
AstraZeneca Pharma India Limited (ASTRAZEN) reports 30% revenue growth in Q1 FY2026-27, reaching INR 6,828 Mn, driven by strong portfolio and strategic partn.
Wockhardt Limited (WOCKPHARMA) launches Wockhardt Antibiotic Academy to tackle antimicrobial resistance and educate healthcare professionals.
Lupin Limited (LUPIN) secures FDA approval for Sodium Zirconium Cyclosilicate Oral Suspension, expanding its therapeutic portfolio.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) reports Q1 FY27 with highest-ever revenue, up 37.1% YoY, driven by strong Pharmaceuticals and Chemicals seg.
Wockhardt Limited (WOCKPHARMA) reports Q1 FY27 results with a PAT of Rs. 107 Cr and revenue up 26% compared to previous year.
Yatharth Hospital & Trauma Care Services Ltd (NSE: YATHARTH) reports record revenue growth of 51% YoY and EBIT DA up 39% YoY for Q1 FY27.
Gland Pharma Limited (NSE: GLAND) reports record revenues for Q1 FY27, with a 20% Y-o-Y growth and a 47% surge in PAT.
Windlas Biotech Limited (WINDLAS) reports Q1FY27 results with 18% YoY revenue growth to Rs 248 crore, EBITDA up 26%, and PAT up 37%.